Selected Publications:
Lorenzo Ramirez, A. T. Charlie Johnson, Cindy Otto, Janos Laszlo Tanyi, Jody Piltz-Seymour, Jae Hyock Kwak, Katharine Prigg, Nicholas Kybert, George Preti; California Lutheran University, Thousand Oaks, CA; University of Pennsylvania Department of Physics & Astronomy, Philadelphia, PA; University of Pennsylvania School of Veterinary Medicine, Philadelphia, PA; University of Pennsylvania, Philadlephia, PA; University of Pennsylvania Perelman School of Medicine, Narberth, PA; Global Spectroscopy 2, Teterboro: Exploring ovarian cancer detection using an interdisciplinary investigation of its volatile odor signature, 2018 ASCO Annual Meeting, Chicago, : 2018.
Tanyi JL, Bobisse S, Ophir E, Tuyaerts S, Roberti A, Genolet R, Baumgartner P, Stevenson BJ, Iseli C, Dangaj D, Czerniecki B, Semilietof A, Racle J, Michel A, Xenarios I, Chiang C, Monos DS, Torigian DA, Nisenbaum HL, Michielin O, June CH, Levine BL, Powell DJ Jr, Gfeller D, Mick R, Dafni U, Zoete V, Harari A, Coukos G, Kandalaft LE.: Personalized cancer vaccine effectively mobilizes antitumor T cell immunity in ovarian cancer Sci Transl Med. : 10(436). ,2018.
Katsnelson M, Hwang WT, Tahirovic E, Rubin SC, Tanyi JL.: Preoperative predictors that impact the survival and outcome of patients undergoing secondary cytoreduction for ovarian cancer. J Obstet Gynaecol : 38(3):395-401,2018.
Bobisse S, Genolet R, Roberti A, Tanyi JL, Racle J, Stevenson BJ, Iseli C, Michel A, Le Bitoux MA, Guillaume P, Schmidt J, Bianchi V, Dangaj D, Fenwick C, Derré L, Xenarios I, Michielin O, Romero P, Monos DS, Zoete V, Gfeller D, Kandalaft LE, Coukos G, Harari A.: Sensitive and frequent identification of high avidity neo-epitope specific CD8 + T cells in immunotherapy-naive ovarian cancer. Nat Commun : 9(1):1092,2018.
Uribe-Herranz M, Bittinger K, Rafail S, Guedan S, Pierini S, Tanes C, Ganetsky A, Morgan MA, Gill S, Tanyi JL, Bushman FD, June CH, Facciabene A.: Gut microbiota modulates adoptive cell therapy via CD8α dendritic cells and IL-12. JCI Insight : 3(4),2018.
O'Hara MH, Stashwick C, Plesa G, Tanyi JL: Overcoming barriers of car T-cell therapy in patients with mesothelin-expressing cancers. Immunotherapy 9(9):767-80 : 2017.
O'Hara MH, Stashwick C, Plesa G, Tanyi JL.: Overcoming barriers of car T-cell therapy in patients with mesothelin-expressing cancers. Immunotherapy : 9(9):767-780,2017.
Yang L, Zhang Y, Shan W, Hu Z, Yuan J, Pi J, Wang Y, Fan L, Tang Z, Li C, Hu X, Tanyi JL, Fan Y, Huang Q, Montone K, Dang CV, Zhang L: Repression of BET activity sensitizes homologous recombination-proficient cancers to PARP inhibition. Sci Transl Med 9(400) : 2017.
Tanyi JL, Stashwick C, Plesa G, Morgan MA, Porter D, Maus MV, June CH: Possible compartmental cytokine release syndrome in a patient with recurrent ovarian cancer after treatment with Mesothelin-targeted CAR-T cells. J Immunother 40(3):104-10 : 2017.
Randall L, Wenham RN, Dowdy SC, Low P, Tanyi JL: A Phase 2, Single-Dose, Open-Label Study to Investigate the Safety and Efficacy of OTL38 Injection (OTL38) for Intra-operative Imaging of Folate Receptor-alpha Positive Ovarian Cancer. SGO 48th Annual Meeting on Women's Cancer. Scientific Plenary Session, Annual Meeting, National Harbor, MD, : 2017.